Ignite Creation Date:
2025-12-24 @ 2:29 PM
Ignite Modification Date:
2025-12-29 @ 10:34 PM
Study NCT ID:
NCT05568459
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2022-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-21
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-23
First Submit QC Date:
None
Study First Post Date:
2022-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED